In an initial work on the role of IL-33 in SSc, Manetti et al. studied the IL-33 protein expression, IL33 mRNA, and ST2 expression in skin and visceral organ biopsies from SSc patients (both early and late) and controls. Here, IL1RL1 is linked to systemic sclerosis.